Section-8 – Defenses Of The Michigan Medical Marihuana Act

Section-8  – Michigan MCL 333-26428

Defenses of The Michigan Medical Marihuana Act


Michigan Medical Marihuana Laws and regulations are constantly changing.  Keep up to date and learn more about the process as well as the evolving requirements to become a patient, caregiver or MMFLA business license holder.

Medical Marihuana Act - Section MCL 333.26428

Section MCL 333.26428 - Defines defenses for Medical Marihuana Patients and Caregivers
<p><span style="font-family: arial, helvetica, sans-serif; font-size: 12pt;">Section MCL 333.333.26428 will define defenses for Medical Marijuana Patients and Caregivers.</span></p> <div id="mypage"> <form id="MainForm" action="mileg.aspx?page=GetMclDocument&objectname=mcl-333-26424" method="post"> <article id="maincontent">Section 8.  Affirmative Defense and Dismissal for Medical Marihuana </article> </form> </div>

Read More About…

Important Marijuana Legal Defenses and Definitions

 

Medical Marihuana Act and Updates

 

Komorn Law Criminal Defense Services


If you or someone you know is facing charges as a result of Medical Marijuana or any other criminal charges contact Komorn Law and ensure your rights are protected.  Michael Komorn is recognized as a leading expert on the Michigan Medical Marihuana Act. He is the President of the Michigan Medical Marijuana Association (MMMA), a nonprofit patient advocacy group which advocates for the rights of medical marijuana patients and their caregivers.

Contact us for a free no-obligation case evaluation at 800-656-3557.

www.komornlaw.com

Disclaimer: Any codes, laws, information on our website(s) may not be the most current version, are not under our control or have been provided by third parties. The laws, regulations and other information may have changed or updated. Although we make an effort to be factual we make no warranties, promises or guarantees about the accuracy, facts, completeness, or adequacy of the information contained on our website, the information provided or sites linked. Please contact us for more information.

Share This